EcoDrugPlus

Cyclin D1

Ensembl ID : ENSBMSG00010005276
Gene Symbol: CCND1
1 Cross references
274 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSBMSG00010013392
Gene Symbol: CDK1
1 Cross references
245 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSBMSG00010007049
Gene Symbol: CDK2
1 Cross references
203 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSBMSG00010010900
Gene Symbol: CDK4
1 Cross references
226 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSBMSG00010012888
Gene Symbol: CDK5
1 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSBMSG00010008966
Gene Symbol: CDK6
1 Cross references
201 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSBMSG00010007947
Gene Symbol: CDK7
1 Cross references
219 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSBMSG00010004332
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSBMSG00010002365
Gene Symbol: CDA
1 Cross references
232 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSBMSG00010015084
Gene Symbol: CYP17A1
1 Cross references
211 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSBMSG00010022052
Gene Symbol: CYP26A1
1 Cross references
208 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSBMSG00010002933
Gene Symbol: CYP46A1
1 Cross references
260 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).